V015-7389 Screening compound: 4-(4-{[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-1,6-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide

V015-7389 Screening compound: 4-(4-{[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-1,6-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide
V015-7389 Screening compound: 4-(4-{[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-1,6-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-7389
4-(4-{[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-1,6-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-7389

Molecular Formula

C29H37N7O2 (C29 H37 N7 O2)

Compound Name

4-(4-{[4-(3,4-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-1,6-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide

IUPAC name

4-(4-{[4-(34-dimethylphenyl)piperazin-1-yl]methyl}-6-oxo-16-dihydropyrimidin-2-yl)-N-(4-methylphenyl)piperazine-1-carboxamide

SMILES

Cc(cc1)ccc1NC(N(CC1)CCN1C(N1)=NC(CN(CC2)CCN2c2cc(C)c(C)cc2)=CC1=O)=O

InChI

InChI=1S/C29H37N7O2/c1-21-4-7-24(8-5-21)31-29(38)36-16-14-35(15-17-36)28-30-25(19-27(37)32-28)20-33-10-12-34(13-11-33)26-9-6-22(2)23(3)18-26/h4-9,18-19H,10-17,20H2,1-3H3,(H,31,38)(H,30,32,37)

InChI Key

RLUDAQCACDPWSZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859989

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

515.66

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.804

Distribution Coefficient, logD

2.303

Water Solubility, LogSw

-3.75

Polar Surface Area

70.633

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

7.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.40

V015-7389 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V015-7389 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-7389?
Check Price and Availability of V015-7389, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-7389 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-7389
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-7389
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-7389 available by request